GGrantIndex
Sort

82,697 grants matching vaccine development

The Southwest National Primate Research Center

$7,420,767
Kenneth Parkhurst Trevett · Texas Biomedical Research Institute · P51 · FY2012 · OD

TULANE NATIONAL PRIMATE RESEARCH CENTER

$7,416,004
Benjamin Paul Sachs · Tulane University Of Louisiana · P51 · FY2007 · RR

TULANE NATINAL PRIMATE RESEARCH CENTER

$7,414,175
Alan Marshall Miller · Tulane University Of Louisiana · P51 · FY2006 · RR

Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) Operations and Collaborations Center (UM2 Clinical Trial Optional)

$7,389,531
Barbara Driver · Westat, Inc. · UM2 · FY2022 · HD

DEVELOPMENT OF ANTHRAX VACCINE FORMULATI0N

$7,386,039
Laurence Lemiale · Emergent Product Development Gaithersbur · N01 · FY2014 · AI

The Southwest National Primate Research Center

$7,367,413
Robert W Gracy · Texas Biomedical Research Institute · P51 · FY2015 · OD

SDMC - IMPAACT Leadership Group

$7,359,781
David Eric Shapiro · Harvard School Of Public Health · UM1 · FY2016 · AI

Clinical Trials of Biodefense Vaccines (Dengue)

$7,347,343
Kanta Subbarao · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI

Southeast Regional Centers of Excellence for Biodefense & Emerging Infectious Di

$7,344,820
Philip Frederick Sparling · Univ Of North Carolina Chapel Hill · U54 · FY2011 · AI

CIVICS)PROGRAM - SARS-CoV-2 STUDIES

$7,342,586
Florian Krammer · Icahn School Of Medicine At Mount Sinai · N01 · FY2020 · AI

Dengue Human Immunology Project Consortium (DHIPC)

$7,340,996
Ana Fernandez-Sesma · Icahn School Of Medicine At Mount Sinai · U19 · FY2018 · AI

Advancement of Vaccines and Treatments for Ebola and Marburg Virus Infections

$7,339,433
Thomas William Geisbert · University Of Texas Med Br Galveston · U19 · FY2020 · AI

The Baltimore Longitudinal Study of Aging

$7,338,699
Eleanor M Simonsick · National Institute On Aging · ZIA · FY2021 · AG

UMB Technology Resource Center

$7,329,060
E Albert Reece · University Of Maryland Baltimore · G20 · FY2010 · RR

GMP Production of Envelope Immunogens

$7,311,966
Leonidas A Stamatatos · Fred Hutchinson Cancer Research Center · U19 · FY2020 · AI

Leadership for HIV/AIDS Clinical Trials Networks; HIV Prevention Trials Network

$7,311,592
Deborah J Donnell · Fred Hutchinson Cancer Research Center · U01 · FY2009 · AI

Tulane National Primate Research Center

$7,308,462
Benjamin Paul Sachs · Tulane University Of Louisiana · P51 · FY2008 · RR

Novel Adenovirus Vector-Based Vaccines for HIV-1

$7,304,539
Dan H. Barouch · Beth Israel Deaconess Medical Center · U19 · FY2006 · AI

NIAID PRECLINICAL DEVELOPMENT SUPPORT - PRODUCTION OF HCMV-TR3∆PP71 HIVGAG FOR CLINICAL TRIALS

$7,292,084
Nancy Lin · Advanced Bioscience Laboratories, Inc. · N01 · FY2014 · AI

Columbia Partnership for Prevention and Control of HIV/AIDS Clinical Trials Unit

$7,286,889
Magdalena Elzbieta Sobieszczyk · Columbia University Health Sciences · UM1 · FY2019 · AI

Sexually Transmitted Infections Clinical Trials Group

$7,280,619
Giudice Linda · · N01 · FY2014 · AI

Malaria Vaccines: Pfs25-rEPA and Pfs230-rEPA

$7,278,594
Patrick Duffy · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI

Vaccine Immunology Program

$7,267,156
Sarah Andrews · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI

Vaccine Immunology Program

$7,267,155
Adrian McDermott · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI

HVTN Laboratory Program

$7,256,662
Margaret Juliana McElrath · Fred Hutchinson Cancer Research Center · UM1 · FY2013 · AI